The technology as tool for other companies with their own product development. We supposedly have someone on board to sell that concept to other companies now. This was discussed for years and long overdue in my opinion. Does not need FDA approval. Potential in income has not been disclosed to my knowledge.
Sepsis may or may NOT be finished by September. US govt could pass or ask for additional tests. Mr. Joyce was clear that guidance won't be given since it's the governments project. It'd be nice to expect it but there's no sense of why one would at this moment.
Things like Zika or Ebola are not clear. Do safety trials have to progress before any quantity of significance can be distributed? I don't know but if I can attend the meeting I will ask.
Cash from isolating a product and selling part of the ownership such as the CTE application. Income but not revenue of course. Most of us wonder why that can't happen to drive up the market cap and improve the enterprise value. Perhaps that will occur after safety trials.
India and medical tourism was dangled by some but in hindsight Aethlon was unable to produce the HP in quantity and also indicated they didn't want to mess up US trials At least the then IR people told me that. It appears getting a Nasdaq listing curtails such musings since India as a revenue source has disappeared.
The poster you responded to has stated the company has done nothing and will do nothing for a couple of years yet posts as often as anyone. A poster on yahoo posts incessently against the company but believes an Ebola apron company is a great investment because newer investors after him are idiots. If you are sincere yourself then ask why they bother.
I believe newer shareholders of size will demand or possibly help the process. This company I believe will succeed or fail within two years. Opinion only. The shareholder meeting better have news and I think if the company has value it cannot go it alone by two or so years. Lots of ifs but Matthew Finston and that ilk have bashed while leaving many things out
apostrophe- Revenues require: 1) Approvals by regulatory bodies ie FDA, other gov'ts 2) Acceptance by the medical community as a viable device. ( Thus far none ) 3) 2-3 more years of work on their trials and studies.
That's it! Nothing else is mneaningful to get this going .
News 
Market Data 
Discover 
